Following in the footsteps of Princess Grace: Monaco & the fight to eradicate polio

The Principality of Monaco has long been a dedicated supporter of the effort to eradicate polio, and is the highest per capita contributor to the Global Polio Eradication Initiative.

Actress Grace Kelly distributed March of Dimes literature to leaders of the Mothers’ march on Polio. © Yale School of Medicine

Even long before the GPEI was formed, Monaco played a leading role in early initiatives to develop a polio vaccine. In the 1950s, Her Serene Highness Princess Grace was an advocate for the National Foundation for Infantile Paralysis in the United States of America, founded by President Franklin D. Roosevelt (himself a polio survivor).

The Foundation became known as the “March of Dimes”, so called because of its far-reaching call for funds to research a cure for polio, which at the time was one of the most serious communicable diseases in the USA. Grants from the NFIP facilitated the work of researchers such as Dr. Jonas Salk, creator of the first successful vaccine against poliovirus. But it also facilitated the work of unsung heroes, such as Dr. Leone Farrell at the University of Toronto’s Connaught Medical Research Laboratories. Farrell devised the “Toronto method” for mass production of vaccines, which made the massive field trials of Salk’s vaccine possible, paving the way for the mass vaccination campaigns which have brought us so far in eradicating polio.

Leone Farrell, PhD, was a key figure in the successful mass production of the polio vaccine, enabling Jonas Salk and his team enough serum to perform the initial polio vaccine trials in 1954. © Sanofi Pasteur Canada Archives

Farrell is one of thousands of women past and present at the forefront of the GPEI. The role of women in polio eradication is supported by Polio Gender Champions, who work to raise the voices of women engaged in the programme, and keep gender equality high on the global public health agenda.

And today, Monaco’s proud tradition of support for gender equality and polio eradication continues, with the announcement that H.E. Ms. Carole Lanteri, Ambassador and Permanent Representative of Monaco to the United Nations Office at Geneva will become the newest Gender Champion for Polio Eradication. The Ambassador, formerly co-chair of the GPEI’s Polio Partners Group, explains the significance of this new role:

“As the Covid-19 pandemic continues to affect our lives, women pay a higher price with regressive effects on gender equality. If gender dynamics are not taken into consideration, polio interventions will not be as effective, with the potential risk of exacerbating existing inequalities. More than ever before we must advocate for a meaningful inclusion of women in decision making processes and adopt policies in health programming to reflect this. Today my commitment to these causes is even stronger thanks to my new role as Gender Champion. Following in the footsteps of Princess Grace and taking forward Monaco’s longstanding commitment to gender equality and polio eradication, I am determined to use my voice to advocate for gender mainstreaming in polio eradication to reach every last child.”

Ambassador Lanteri joins the ranks of other gender champions striving to raise awareness of the role of women in polio eradication and on the importance of addressing gender related barriers to immunization. Their work will be instrumental not only in eradicating polio, but also in creating a legacy for recognizing and empowering the role of women in major public health initiatives.


Related News

   04/08/2021
As of 4 August 2021
   26/07/2021
Funding to be used to vaccinate more than 16 million children in 84 highest risk districts
   15/06/2021
Value of polio infrastructure in COVID-19 support continues to be highlighted
   10/06/2021
Support critical ahead of launch of new strategic plan
   10/06/2021
Renewed donor support critical to ending polio after recent rise in cases and COVID-19 setbacks
   01/06/2021
New strategy sets out roadmap for polio-free world amid COVID-19